Kyzatrex — Medica
Gender-dysphoric/gender-incongruent persons undergoing female-to-male (FTM) gender reassignment (endocrinologic masculinization)
Initial criteria
- Prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of transgender patients
Reauthorization criteria
- Prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of transgender patients
Approval duration
1 year